Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence

Thalheimer U; Mela M; Patch D; Burroughs A K
January 2004
Gut;Jan2004, Vol. 53 Issue 1, p143
Academic Journal
Recurrent variceal bleeding is very frequent after variceal haemorrhage and pharmacological therapy is the first choice treatment. Recently, baseline and repeat measurements of hepatic venous pressure gradient (HVPG) have been considered necessary to optimally manage patients receiving pharmacological therapy so as to reduce the frequency of rebleeding. However, the clinical validity and applicability of monitoring for target HVPG reductions is not sufficiently proven and needs to be specifically evaluated in a prospective trial.


Related Articles

  • Diagnosis and Treatment of Gastrointestinal Bleeding Secondary to Portal Hypertension. Grace, Norman D. // American Journal of Gastroenterology;Jul1997, Vol. 92 Issue 7, p1081 

    Guidelines for clinical practice are intended to suggest preferable approaches to particular medical problems as established by interpretation and collation of scientifically valid research, derived from extensive review of published literature. When data are not available that will withstand...

  • FREQUENCY OF HEMORRHAGE OR INFARCTION IN HYPERTENSIVE STROKE PATIENTS. Maitlo, Hussain Bux; Shaikh, Tariq Zaffar; Shaikh, Abdul Haleem; Ghori, Rafi Ahmed; Khan, Mashood A. // Medical Channel;Oct2010, Vol. 16 Issue 4, p506 

    OBJECTIVE:- To determine frequency of hemorrhage or Infraction in hypertensive stroke patients. TYPE OF STUDY: Descriptive type of study PLACE OF STUDY: This study was carried out in Medical Unit 1 Liquat Medical & Health Sciences Hospital Jamshoro in collaboration with Radiology Department...

  • Clinical Renal Pharmacology and Therapeutics.  // Kidney;Jan/Feb2002, Vol. 11 Issue 1, p43 

    Presents abstracts of studies related to clinical renal pharmacology and therapeutics. Comparison of the responses to adrenergic blockade in obese and lean hypertensive patients; Efficacy and safety of cefepime versus vancomycin plus netilmicin therapy for treating continuous ambulatory...

  • High thresholds skew figures on hypertension. Baines, Emma // GP: General Practitioner;11/25/2005, p15 

    The article presents data and figures related to hypertension. According to Peter Sever, professor of clinical pharmacology and therapeutics at Imperial College London, England and member of the British Hypertension Society the data did not give an accurate representation of the real prevalence...

  • Prevention of First Variceal Bleed: An Appraisal of Current Therapies. Shahi, Hansa M.; Sarin, Shiv K. // American Journal of Gastroenterology;Dec1998, Vol. 93 Issue 12, p2348 

    Primary prophylaxis of esophageal variceal hemorrhage (EVH) is an important issue in the management of patients with portal hypertension. Given the high rates of initial variceal hemorrhage and mortality in patients who have not experienced bleeding from varices, there is an urgent need for some...

  • Discontinuing BP medications significantly increases the risk of stroke.  // Modern Medicine;Aug98, Vol. 66 Issue 8, p36 

    Presents an abstract of the article `Three Important Subgroups of Hypertensive Persons at Greater Risk of Intracerebral Hemorrhage,' by A. G. Thrift, J. J. McNeil, A. Forbes, et al from the `Hypertension' dated June 1998.

  • Clinical Renal Pharmacology and Therapeutics.  // Kidney;Jan/Feb2002, Vol. 11 Issue 1, p39 

    Presents abstracts of studies related to clinical renal pharmacology and therapeutics. Assessment of the influence of antihypertensive therapy with losartan in male hypertensive patients with sexual dysfunction; Investigation of the progression of renal dysfunction in survivors of pediatric...

  • Reducing the Risk of Type 2 Diabetes - Early Identification of High-Risk Individuals and Treatment with Acarbose. Chang-Yu Pan // Current Diabetes Reviews;2007, Vol. 3 Issue 2, p141 

    The severity of the type 2 diabetes epidemic is widely acknowledged. Demographic, social, and cultural changes around the world are driving a dramatic increase in the prevalence of type 2 diabetes. Consequently, there is increasing interest in defining the target population and developing...

  • Chlorthalidone for hypertension. Elliott, William T. // Neurology Alert;May2013, Vol. 31 Issue 9, Special section p2 

    The article discusses research published in a 2013 issue of "Annals of Internal Medicine" which found that chlorthalidone may cause more electrolyte abnormalities than hydrochlorothiazide (HCTZ).


Read the Article


Sign out of this library

Other Topics